| scholarly article | Q13442814 |
| P2093 | author name string | Ricardo Blanco | |
| Miguel A González-Gay | |||
| Javier Llorca | |||
| Carlos González-Juanatey | |||
| Fernanda Genre | |||
| Raquel López-Mejías | |||
| Inés Gómez-Acebo | |||
| Beatriz Carnero-López | |||
| Javier Rueda | |||
| Jose A Miranda-Filloy | |||
| Rodrigo Ochoa | |||
| P433 | issue | 5 | |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| TNF | Q18032037 | ||
| P304 | page(s) | 749-755 | |
| P577 | publication date | 2013-06-14 | |
| P1433 | published in | Clinical and Experimental Rheumatology | Q15759225 |
| P1476 | title | Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy | |
| P478 | volume | 31 |
| Q37686803 | Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q33593925 | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration |
| Q34250990 | IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapy |
| Q33747796 | Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect |
| Q37327034 | Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis |
| Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
Search more.